Transient Visual Loss in a Hepatitis C Patient Treated With Pegylated Interferon Alfa-2a and Ribavirin

INTRODUCTION: Patients with Hepatitis C are commonly treated with combination of Pegylated Interferon alfa-2a and Ribavirin. Less than 1% of patients receiving this treatment experience very uncommon ophthalmological side effects such as optic neuropathy and vision disorder, which are usually subcli...

Descripción completa

Detalles Bibliográficos
Autores principales: Jancoriene, Ligita, Norvydaite, Dovile, Galgauskas, Saulius, Balciunaite, Evelina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950629/
https://www.ncbi.nlm.nih.gov/pubmed/24693308
http://dx.doi.org/10.5812/hepatmon.15124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950629/
https://www.ncbi.nlm.nih.gov/pubmed/24693308
http://dx.doi.org/10.5812/hepatmon.15124

Ejemplares similares